| Literature DB >> 26236181 |
Belinda Pletzer1, Ourania Petasis2, Tuulia M Ortner3, Larry Cahill2.
Abstract
Sex role orientation, i.e., a person's masculinity or femininity, influences cognitive and emotional performance, like biological sex. While it is now widely accepted that sex differences are modulated by the hormonal status of female participants (menstrual cycle, hormonal contraceptive use), the question, whether hormonal status and sex hormones also modulate participants sex role orientation has hardly been addressed previously. The present study assessed sex role orientation and hormonal status as well as sex hormone levels in three samples of participants from two different cultures (Northern American, Middle European). Menstrual cycle phase did not affect participant's masculinity or femininity, but had a significant impact on reference group. While women in their follicular phase (low levels of female sex hormones) determined their masculinity and femininity in reference to men, women in their luteal phase (high levels of female sex hormones) determined their masculinity and femininity in reference to women. Hormonal contraceptive users rated themselves as significantly more feminine and less masculine than naturally cycling women. Furthermore, the impact of biological sex on the factorial structure of sex role orientation as well as the relationship of estrogen to masculinity/femininity was modulated by culture. We conclude that culture and sex hormones interactively affect sex role orientation and hormonal status of participants should be controlled for when assessing masculinity and/or femininity.Entities:
Keywords: hormonal contraceptives; menstrual cycle; sex hormones; sex role
Year: 2015 PMID: 26236181 PMCID: PMC4500910 DOI: 10.3389/fnins.2015.00240
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Age [ ± (years)] of men and women in the three samples.
| (a) California – PP | 21.19 ± 3.13 | 20.30 ± 1.73 | 19.96 ± 1.81 |
| (b) Austria – PP | 24.56 ± 4.36 | 23.27 ± 3.80 | 21.72 ± 3.30 |
| (c) Austria – Online | 26.71 ± 10.16 | 24.63 ± 6.22 | 22.44 ± 3.35 |
OC, oral contraceptive; PP, paper and pencil.
Cycle data of the naturally cycling groups among the three samples.
| (a) California – PP | 29.19 ± 3.52 | 18 | 7.89 ± 4.27 | 22 | 25.59 ± 6.34 |
| (b) Austria – PP | 29.72 ± 3.62 | 36 | 7.36 ± 3.71 | 31 | 24.26 ± 7.91 |
| (c) Austria – Online | 29.03 ± 3.22 | 31 | 7.06 ± 4.38 | 28 | 23.11 ± 4.65 |
Figure 1Six item sex role scale (English version).
Figure 2Median of the six sex role ratings in men, follicular women, luteal women and OC users of the three samples. Men rate themselves more masculine and less feminine than women. Follicular and luteal women did not differ in their ratings. OC-users rate themselves more feminine less masculine than naturally cycling women. All groups rate themselves more masculine and less feminine in reference to women than in reference to men. Ratings in reference to the entire population do not equal the mean of ratings in reference to men and women. PP, paper-and-pencil; OC, oral contraceptive; masc, masculine; fem, feminine; M, in reference to men; F, in reference to women; ALL, in reference to the entire population; min, minimum rating; max, maximum rating. Ratings significantly higher than in the other groups: *all p < 0.05, **all p < 0.01, ***all p < 0.001; ratings significantly lower than in the other groups: #all p < 0.05, ##all p < 0.01, ###all p < 0.001. (A) California – PP, (B) Austria – PP, (C) Austria – Online.
Results of stepwise multiple regression for men, naturally cycling women and oral contraceptive (OC) users in the three samples.
| MascM | ENT | 0.66 | 5.16 | ENT | 0.81 | 5.49 | REM | 0.04 | 0.24 | E/R | 0.46 | 3.80 |
| MascF | REM | 0.28 | 1.94 | REM | 0.34 | 1.94 | ENT | 0.78 | 5.65 | ENT | 0.82 | 6.96 |
| FemM | ENT | 0.82 | 8.42 | ENT | 0.78 | 4.99 | REM | −0.07 | −0.35 | REM | −0.04 | −0.25 |
| FemF | REM | 0.20 | 1.53 | REM | 0.32 | 1.72 | ENT | 0.87 | 8.06 | ENT | 0.78 | 6.03 |
| MascM | ENT | 0.75 | 11.04 | ENT | 0.69 | 5.57 | R/E | 0.32 | 2.47 | REM | 0.13 | 0.92 |
| MascF | R/E | 0.32 | 4.70 | R/E | 0.47 | 4.11 | ENT | 0.75 | 6.09 | ENT | 0.68 | 5.95 |
| FemM | ENT | 0.85 | 15.61 | R/E | 0.34 | 2.47 | REM | 0.24 | 1.83 | REM | 0.21 | 1.53 |
| FemF | R/E | 0.25 | 4.31 | ENT | 0.63 | 4.78 | ENT | 0.75 | 6.18 | ENT | 0.49 | 3.61 |
| MascM | ENT | 0.76 | 9.76 | R/E | 0.48 | 4.17 | R/E | 0.30 | 2.47 | R/E | 0.49 | 8.37 |
| MascF | REM | 0.19 | 1.80 | ENT | 0.67 | 4.95 | ENT | 0.86 | 9.21 | ENT | 0.81 | 12.39 |
| FemM | R/E | 0.37 | 3.84 | REM | 0.17 | 1.18 | REM | 0.23 | 1.72 | R/E | 0.32 | 4.45 |
| FemF | ENT | 0.72 | 8.70 | ENT | 0.69 | 7.35 | ENT | 0.80 | 7.35 | ENT | 0.79 | 11.45 |
MascM, masculinity in reference to men; mascF, masculinity in reference to women; femM, femininity in reference to men; femF, femininity in reference to women.
Tested as predictors of masculinity in reference to the entire population.
Tested as predictors of femininity in reference to the entire population.
p < 0.05,
p < 0.01,
p < 0.001, ENT, variable entered by procedure; REM, variable removed by procedure; R/E, removal yields better model, but entry of variable also admissible. For ENT variables the β- and t-values for sole entry are reported, for REM or R/E variables the β- and t-values as if entered are reported. Reference groups were determined from ENT variables and marked light gray.
Hormone levels ( ± ).
| Men ( | 156.93±50.47 | 2.34±0.94 | 73.00±50.47 |
| Follicular ( | 74.44±27.93 | 2.64±0.89 | 76.94±37.36 |
| Luteal ( | 64.89±20.39 | 3.14±0.98 | 148.58±109.28 |
| OC ( | 49.78±27.77 | 2.60±1.01 | |
| Men ( | 112.87±47.12 | 2.63±0.80 | 94.21±97.98 |
| Follicular ( | 46.76±19.17 | 2.51±0.83 | 71.38±74.61 |
| Luteal ( | 53.12±27.27 | 2.83±1.48 | 385.68±382.57 |
Significantly lower than in men.
Significantly lower than in luteal women.
p < 0.01,
p < 0.001.
Varimax rotated solution of principal components analysis with open number of factors.
| mascM | −0.85 | 0.92 | 0.85 | 0.89 | ||||
| MascF | −0.74 | 0.82 | 0.81 | 0.86 | ||||
| mascALL | −0.80 | 0.94 | 0.78 | 0.92 | ||||
| FemM | 0.88 | 0.91 | 0.81 | −0.74 | ||||
| FemF | 0.81 | 0.84 | 0.92 | −0.87 | ||||
| femALL | 0.89 | 0.91 | 0.95 | −0.83 | ||||
| Variance | 68.80 | 10.25 | 48.25 | 35.17 | 62.11 | 19.34 | 73.00 | 11.82 |
| PCA solution | 1 component | 2 components | 2 components | 1 component | ||||
| mascM | 0.83 | 0.94 | 0.65 | 0.72 | ||||
| MascF | 0.80 | −0.68 | 0.83 | 0.82 | ||||
| mascALL | 0.86 | 0.76 | 0.88 | 0.80 | ||||
| FemM | 0.92 | −0.72 | −0.70 | −0.57 | ||||
| FemF | 0.64 | 0.92 | −0.81 | −0.67 | ||||
| femALL | 0.94 | 0.78 | −0.83 | −0.70 | ||||
| Variance | 58.66 | 18.87 | 53.34 | 21.35 | 62.03 | 16.51 | 51.35 | 16.49 |
| PCA solution | 2 components | 2 components | 1 component | 1 component | ||||
| MascM | 0.91 | 0.93 | 0.80 | 0.77 | ||||
| mascF | 0.84 | −0.62 | 0.52 | 0.94 | 0.85 | |||
| mascALL | 0.88 | 0.87 | 0.95 | 0.88 | ||||
| FemM | 0.91 | 0.93 | 0.82 | −0.75 | ||||
| femF | 0.76 | 0.67 | 0.86 | −0.80 | ||||
| FemALL | 0.87 | 0.89 | 0.78 | −0.83 | ||||
| Variance | 60.88 | 19.91 | 50.22 | 26.63 | 57.86 | 23.30 | 66.11 | 15.68 |
| PCA solution | 2 components | 2 components | 2 components | 1 component | ||||
MascM, masculinity in reference to men; mascF, masculinity in reference to women; mascALL, masculinity in reference to the entire population; femM, femininity in reference to men; femF, femininity in reference to women; femALL, femininity in reference to the entire population.
Frequency [%] of Typologies among men and women in the three samples.
| Indiff. | low | low | 16.2 | 11.1 | 9.1 | 4.0 | 10.4 | 22.2 | 25.8 | 18.6 | 21.9 | 19.4 | 14.3 | 7.3 |
| Male | high | low | 78.4 | 5.6 | 0.0 | 4.0 | 79.2 | 2.8 | 3.2 | 4.7 | 76.7 | 3.2 | 14.3 | 9.8 |
| Female | low | high | 5.4 | 72.2 | 81.8 | 88.0 | 4.2 | 69.4 | 67.7 | 74.4 | 0.0 | 71.0 | 64.3 | 74.4 |
| Androgyn | high | High | 0.0 | 11.1 | 9.1 | 4.0 | 6.3 | 5.6 | 3.2 | 2.3 | 1.4 | 6.5 | 7.1 | 8.5 |
Foll., follicular; OC, Oral contraceptive; indiff., indifferent; PP, paper and pencil; masc, masculinity; fem, femininity.
Percentage of participants naming features as explanation for their sex role ratings that were categorized to the categories on the left.
| CALIFORNIA – PP | |||||
| Face and body | 0 | 11 | 0 | 0 | 2 |
| Beauty care | 0 | 28 | 18 | 6 | 10 |
| Activities | 5 | 22 | 23 | 12 | 13 |
| Social contacts | 0 | 17 | 9 | 0 | 4 |
| Personality | 5 | 17 | 9 | 3 | 7 |
| Emotion | 3 | 0 | 0 | 3 | 2 |
| Cognition | 0 | 0 | 0 | 3 | 1 |
| AUSTRIA – ONLINE | |||||
| Face and body | 4 | 6 | 0 | 7 | 5 |
| Beauty care | 4 | 12 | 22 | 7 | 9 |
| Activities | 7 | 6 | 25 | 7 | 10 |
| Social contacts | 3 | 6 | 9 | 9 | 6 |
| Personality | 18 | 16 | 22 | 21 | 19 |
| Emotion | 4 | 6 | 3 | 0 | 3 |
| Cognition | 1 | 9 | 0 | 2 | 3 |